Innovation and early commercialization

Innovation and early commercialization

The Novo Nordisk Foundation supports innovation and the early commercialization of scientific discoveries. The aim is to support new ideas and discoveries being further developed into new products and solutions to benefit people and the environment. The Foundation will achieve this by supporting the establishment of new life science and bioindustrial companies that can also contribute to increasing economic activity and growth in society.

We want to link discoveries and their commercial application and thereby create solutions that would not otherwise have been developed and thereby create added value from the research to benefit everyone.

The various stages of the innovation value chain require different types of support as the technical and commercial activities and requirements develop during the process. We therefore apply a range of initiatives that cover the whole innovation chain from research discoveries to commercialization.

Among other benefits, the various activities the Foundation supports provide access and contacts to important actors within research, clinical communities and industrial networks, so that these initiatives naturally catalyse the interdisciplinary dialogue and activities needed to promote innovation.

Our future activities will especially focus on promoting early innovation, accelerating innovation more broadly, creating incubation environments and strengthening the translational research ecosystem.